Patients with diabetes demand extra care to manage their blood pressure during the ongoing pandemic says, Dr. Gonsalves
Sinopharm, a state-controlled firm said that a vaccine candidate made by its Beijing Institute of Biological Products arm had an efficacy rate of 79%
Covid-19 took up most of our attention in 2020, but here's a look at some other significant events around the world, lest you missed them
Amid the Covid-19 gloom, many things went right too. Here are some sunny stories from the year
As the UK approves the AstraZeneca vaccine for Emergency Use Authorisation (EUA), here's everything you need to know about the vaccine, which is awaiting approval in India
Unlike their Western competitors, the Chinese companies have not disclosed data from late-stage clinical trials that shows vaccine efficacy, and regulators in China have not officially approved them
He dressed the famous, but he was also a licensing pioneer, a merchant to the general public with his name on a cornucopia of products
Every pandemic that tore through the Indian subcontinent like in 2020, brought businesses to a standstill. In 1907, India's GDP contracted by 5 percent, and in 1918 India's GDP fell 10 percent while inflation was high, creating a supply-side shock as 20 million Indians died. The Age of Pandemics by Chinmay Tumbe argues the close connection between pandemics, economics, and politics that have shaped Indian history and why we need to give a central role to pandemics
The Forbes India team believes in work hard, play harder—here are some of the shows—old and new—we watched in 2020
Dr. Kulkarni highlights risk factors for hypertension and discusses various practices to reduce the risk of high blood pressure amid COVID-19 outburst
In a year that kept us at home, the Forbes India team found, or made, more time to read. Here's a compilation of our favourite books of the year